Anti-Embolism Stockings Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for anti-embolism stockings. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights: Anti-Embolism Stockings Market

Market Size (2024E): USD 794 Million
Projected Market Value (2032F): USD 1199.6 Million
Global Market Growth Rate (CAGR 2024 to 2032):5.3%

Anti-Embolism Stockings Market - Report Scope:

Anti-embolism stockings play a crucial role in the prevention of deep vein thrombosis (DVT) and other venous thromboembolic events (VTEs). These stockings apply graduated compression to the legs, enhancing blood circulation and reducing the risk of clot formation. The anti-embolism stockings market caters to hospitals, clinics, outpatient surgical centers, and homecare settings, offering a range of stocking types and compression levels to meet diverse patient needs. Market growth is driven by increasing awareness of VTE prevention, rising incidences of chronic venous disorders, and advancements in stocking materials and designs.

Market Growth Drivers:

The global anti-embolism stockings market is propelled by several key factors, including the growing awareness about VTE prevention among healthcare providers and patients. The rising number of surgical procedures and the increasing prevalence of conditions such as obesity, cancer, and cardiovascular diseases, which heighten the risk of DVT, further drive market expansion. Technological advancements, such as the development of stockings with improved breathability, comfort, and antimicrobial properties, enhance patient compliance and treatment outcomes, fostering market growth. Moreover, the growing adoption of home-based care and preventive healthcare practices creates new avenues for market players to reach a broader patient population.

Market Restraints:

Despite promising growth prospects, the anti-embolism stockings market faces challenges related to patient compliance, reimbursement policies, and competition from alternative VTE prevention methods. Patient adherence to wearing compression stockings consistently can be low due to discomfort or inconvenience, impacting treatment efficacy. Limited reimbursement coverage for anti-embolism stockings and the high cost of premium products pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these challenges requires education initiatives to improve patient compliance and advocacy for better reimbursement policies to promote access to effective VTE prevention solutions.

Market Opportunities:

The anti-embolism stockings market presents significant growth opportunities driven by demographic trends, technological innovations, and evolving healthcare delivery models. The aging global population and the rising incidence of chronic diseases create a growing demand for preventive healthcare products, including anti-embolism stockings. The integration of smart textiles and digital health technologies, such as wearable sensors for real-time monitoring of compression levels and patient compliance, enhances product functionality and patient outcomes. Strategic partnerships, investment in research and development, and the introduction of cost-effective, user-friendly anti-embolism stockings are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic anti-embolism landscape.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the anti-embolism stockings market globally?
Which stocking types and applications are driving anti-embolism stockings adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the anti-embolism stockings market?
Who are the key players contributing to the anti-embolism stockings market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global anti-embolism stockings market?

Competitive Intelligence and Business Strategy:

Leading players in the global anti-embolism stockings market, including Sigvaris, Medi GmbH & Co. KG, and BSN Medical Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced anti-embolism stockings with enhanced comfort, durability, and therapeutic efficacy, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving anti-embolism landscape.

Key Companies Profiled:

Medtronic (Covidien)
Sigvaris
Medi
BSN Medical
Juzo
3M
Bauerfeind AG
Thuasne Corporate
Pretty Legs Hosiery
Salzmann-Group
Paul Hartmann
Cizeta Medicali
Belsana Medical
Gloria Med

Anti-Embolism Stockings Industry Research Segmentation

By Product:

Calf-length
Thigh-length

By Demography:

Men
Women

By End User:

Ambulatory Patients
Post-operative Patients
Pregnant Women

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Product Code: PMRREP33355

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Key Promotional Strategies by Manufacturers
4.2. Regulatory Landscape
4.3. Value Chain Analysis
4.4. Product Adoption Analysis
4.5. PESTEL Analysis
4.6. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Historical Growth of Top Companies
- 5.2.2. Adoption Rate
- 5.2.3. Technology Advancements
- 5.2.4. Increasing Deep Vein Thrombosis Cases
- 5.2.5. Product Pricing
- 5.2.6. Favorable Reimbursement Policies
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Demography
- 6.1.3. By End User
- 6.1.4. By Region
6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2032

7.1. Historical Market Volume (Units) Analysis, 2019-2023
7.2. Current and Future Market Volume (Units) Projections, 2024-2032
- 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
- 8.2.1. Manufacturer Level Pricing
- 8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
- 9.2.1. Y-o-Y Growth Trend Analysis
- 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Product

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2032
- 10.3.1. Calf Length
- 10.3.2. Thigh Length
10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Demography

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By Demography, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Demography, 2024-2032
- 11.3.1. Men
- 11.3.2. Women
11.4. Market Attractiveness Analysis By Demography

12. Global Market Analysis 2019-2023 and Forecast 2024-2032, By End User

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis Forecast By End User, 2024-2032
- 12.3.1. Ambulatory Patients
- 12.3.2. Post-Operative Patients
- 12.3.3. Pregnant Women
- 12.3.4. Others
12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Region

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
13.3. Current and Future Market Value (US$ Mn) Projections, 2024-2032
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. East Asia
- 13.3.5. South Asia
- 13.3.6. Oceania
- 13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2032

14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
- 14.3.1. By Country
  - 14.3.1.1. U.S.
  - 14.3.1.2. Canada
- 14.3.2. By Product
- 14.3.3. By Demography
- 14.3.4. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Demography
- 14.4.4. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
- 14.7.1. U.S. Market Analysis
  - 14.7.1.1. Introduction
  - 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.7.1.2.1. By Product
    - 14.7.1.2.2. By Demography
    - 14.7.1.2.3. By End User
- 14.7.2. Canada Market Analysis
  - 14.7.2.1. Introduction
  - 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.7.2.2.1. By Product
    - 14.7.2.2.2. By Demography
    - 14.7.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2032

15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
- 15.3.1. By Country
  - 15.3.1.1. Brazil
  - 15.3.1.2. Mexico
  - 15.3.1.3. Argentina
  - 15.3.1.4. Rest of Latin America
- 15.3.2. By Product
- 15.3.3. By Demography
- 15.3.4. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Demography
- 15.4.4. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
- 15.7.1. Brazil Market Analysis
  - 15.7.1.1. Introduction
  - 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.7.1.2.1. By Product
    - 15.7.1.2.2. By Demography
    - 15.7.1.2.3. By End User
- 15.7.2. Mexico Market Analysis
  - 15.7.2.1. Introduction
  - 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.7.2.2.1. By Product
    - 15.7.2.2.2. By Demography
    - 15.7.2.2.3. By End User
- 15.7.3. Argentina Market Analysis
  - 15.7.3.1. Introduction
  - 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.7.3.2.1. By Product
    - 15.7.3.2.2. By Demography
    - 15.7.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2032

16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
- 16.3.1. By Country
  - 16.3.1.1. U.K.
  - 16.3.1.2. Germany
  - 16.3.1.3. Italy
  - 16.3.1.4. France
  - 16.3.1.5. Spain
  - 16.3.1.6. Russia
  - 16.3.1.7. BENELUX
  - 16.3.1.8. Rest of Europe
- 16.3.2. By Product
- 16.3.3. By Demography
- 16.3.4. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Demography
- 16.4.4. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
- 16.7.1. U.K. Market Analysis
  - 16.7.1.1. Introduction
  - 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.7.1.2.1. By Product
    - 16.7.1.2.2. By Demography
    - 16.7.1.2.3. By End User
- 16.7.2. Germany Market Analysis
  - 16.7.2.1. Introduction
  - 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.7.2.2.1. By Product
    - 16.7.2.2.2. By Demography
    - 16.7.2.2.3. By End User
- 16.7.3. Italy Market Analysis
  - 16.7.3.1. Introduction
  - 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.7.3.2.1. By Product
    - 16.7.3.2.2. By Demography
    - 16.7.3.2.3. By End User
- 16.7.4. France Market Analysis
  - 16.7.4.1. Introduction
  - 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
    - 16.7.4.2.1. By Product
    - 16.7.4.2.2. By Demography
    - 16.7.4.2.3. By End User
- 16.7.5. Spain Market Analysis
  - 16.7.5.1. Introduction
  - 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
    - 16.7.5.2.1. By Product
    - 16.7.5.2.2. By Demography
    - 16.7.5.2.3. By End User
- 16.7.6. Russia Market Analysis
  - 16.7.6.1. Introduction
  - 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
    - 16.7.6.2.1. By Product
    - 16.7.6.2.2. By Demography
    - 16.7.6.2.3. By End User
- 16.7.7. BENELUX Market Analysis
  - 16.7.7.1. Introduction
  - 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
    - 16.7.7.2.1. By Product
    - 16.7.7.2.2. By Demography
    - 16.7.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2032

17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
- 17.3.1. By Country
  - 17.3.1.1. China
  - 17.3.1.2. Japan
  - 17.3.1.3. South Korea
- 17.3.2. By Product
- 17.3.3. By Demography
- 17.3.4. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Demography
- 17.4.4. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
- 17.7.1. China Market Analysis
  - 17.7.1.1. Introduction
  - 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.7.1.2.1. By Product
    - 17.7.1.2.2. By Demography
    - 17.7.1.2.3. By End User
- 17.7.2. Japan Market Analysis
  - 17.7.2.1. Introduction
  - 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.7.2.2.1. By Product
    - 17.7.2.2.2. By Demography
    - 17.7.2.2.3. By End User
- 17.7.3. South Korea Market Analysis
  - 17.7.3.1. Introduction
  - 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.7.3.2.1. By Product
    - 17.7.3.2.2. By Demography
    - 17.7.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2032

18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
- 18.3.1. By Country
  - 18.3.1.1. India
  - 18.3.1.2. Indonesia
  - 18.3.1.3. Malaysia
  - 18.3.1.4. Thailand
  - 18.3.1.5. Rest of South Asia
- 18.3.2. By Product
- 18.3.3. By Demography
- 18.3.4. By End User
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Demography
- 18.4.4. By End User
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
- 18.7.1. India Market Analysis
  - 18.7.1.1. Introduction
  - 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.7.1.2.1. By Product
    - 18.7.1.2.2. By Demography
    - 18.7.1.2.3. By End User
- 18.7.2. Indonesia Market Analysis
  - 18.7.2.1. Introduction
  - 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.7.2.2.1. By Product
    - 18.7.2.2.2. By Demography
    - 18.7.2.2.3. By End User
- 18.7.3. Malaysia Market Analysis
  - 18.7.3.1. Introduction
  - 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 18.7.3.2.1. By Product
    - 18.7.3.2.2. By Demography
    - 18.7.3.2.3. By End User
- 18.7.4. Thailand Market Analysis
  - 18.7.4.1. Introduction
  - 18.7.4.2. Market Analysis and Forecast by Market Taxonomy
    - 18.7.4.2.1. By Product
    - 18.7.4.2.2. By Demography
    - 18.7.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2032

19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
- 19.3.1. By Country
  - 19.3.1.1. Australia
  - 19.3.1.2. New Zealand
- 19.3.2. By Product
- 19.3.3. By Demography
- 19.3.4. By End User
19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Product
- 19.4.3. By Demography
- 19.4.4. By End User
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
19.7. Country Level Analysis & Forecast
- 19.7.1. Australia Market Analysis
  - 19.7.1.1. Introduction
  - 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 19.7.1.2.1. By Product
    - 19.7.1.2.2. By Demography
    - 19.7.1.2.3. By End User
- 19.7.2. New Zealand Market Analysis
  - 19.7.2.1. Introduction
  - 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 19.7.2.2.1. By Product
    - 19.7.2.2.2. By Demography
    - 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2032

20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
20.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2024-2032
- 20.3.1. By Country
  - 20.3.1.1. GCC Countries
  - 20.3.1.2. Turkiye
  - 20.3.1.3. South Africa
  - 20.3.1.4. Rest of Middle East and Africa
- 20.3.2. By Product
- 20.3.3. By Demography
- 20.3.4. By End User
20.4. Market Attractiveness Analysis
- 20.4.1. By Country
- 20.4.2. By Product
- 20.4.3. By Demography
- 20.4.4. By End User
20.5. Market Trends
20.6. Drivers and Restraints - Impact Analysis
20.7. Country Level Analysis & Forecast
- 20.7.1. GCC Countries Market Analysis
  - 20.7.1.1. Introduction
  - 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
    - 20.7.1.2.1. By Product
    - 20.7.1.2.2. By Demography
    - 20.7.1.2.3. By End User
- 20.7.2. Turkiye Market Analysis
  - 20.7.2.1. Introduction
  - 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
    - 20.7.2.2.1. By Product
    - 20.7.2.2.2. By Demography
    - 20.7.2.2.3. By End User
- 20.7.3. South Africa Market Analysis
  - 20.7.3.1. Introduction
  - 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
    - 20.7.3.2.1. By Product
    - 20.7.3.2.2. By Demography
    - 20.7.3.2.3. By End User

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis

22. Competition Analysis

22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
- 22.3.1. MD
  - 22.3.1.1. Overview
  - 22.3.1.2. Product Portfolio
  - 22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.1.4. Sales Footprint
  - 22.3.1.5. Key Financials
  - 22.3.1.6. SWOT Analysis
  - 22.3.1.7. Strategy Overview
- 22.3.2. Medtronic(Covidien)
  - 22.3.2.1. Overview
  - 22.3.2.2. Product Portfolio
  - 22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.2.4. Sales Footprint
  - 22.3.2.5. Key Financials
  - 22.3.2.6. SWOT Analysis
  - 22.3.2.7. Strategy Overview
- 22.3.3. Sigvaris, Medi
  - 22.3.3.1. Overview
  - 22.3.3.2. Product Portfolio
  - 22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.3.4. Sales Footprint
  - 22.3.3.5. Key Financials
  - 22.3.3.6. SWOT Analysis
  - 22.3.3.7. Strategy Overview
- 22.3.4. BSN Medical
  - 22.3.4.1. Overview
  - 22.3.4.2. Product Portfolio
  - 22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.4.4. Sales Footprint
  - 22.3.4.5. Key Financials
  - 22.3.4.6. SWOT Analysis
  - 22.3.4.7. Strategy Overview
- 22.3.5. Juzo
  - 22.3.5.1. Overview
  - 22.3.5.2. Product Portfolio
  - 22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.5.4. Sales Footprint
  - 22.3.5.5. Key Financials
  - 22.3.5.6. SWOT Analysis
  - 22.3.5.7. Strategy Overview
- 22.3.6. 3M
  - 22.3.6.1. Overview
  - 22.3.6.2. Product Portfolio
  - 22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.6.4. Sales Footprint
  - 22.3.6.5. Key Financials
  - 22.3.6.6. SWOT Analysis
  - 22.3.6.7. Strategy Overview
- 22.3.7. Bauerfeind AG
  - 22.3.7.1. Overview
  - 22.3.7.2. Product Portfolio
  - 22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.7.4. Sales Footprint
  - 22.3.7.5. Key Financials
  - 22.3.7.6. SWOT Analysis
  - 22.3.7.7. Strategy Overview
- 22.3.8. Thuasne Corporate
  - 22.3.8.1. Overview
  - 22.3.8.2. Product Portfolio
  - 22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.8.4. Sales Footprint
  - 22.3.8.5. Key Financials
  - 22.3.8.6. SWOT Analysis
  - 22.3.8.7. Strategy Overview
- 22.3.9. Pretty Legs Hosiery
  - 22.3.9.1. Overview
  - 22.3.9.2. Product Portfolio
  - 22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.9.4. Sales Footprint
  - 22.3.9.5. Key Financials
  - 22.3.9.6. SWOT Analysis
  - 22.3.9.7. Strategy Overview
- 22.3.10. Salzmann-Group
  - 22.3.10.1. Overview
  - 22.3.10.2. Product Portfolio
  - 22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.10.4. Sales Footprint
  - 22.3.10.5. Key Financials
  - 22.3.10.6. SWOT Analysis
  - 22.3.10.7. Strategy Overview
- 22.3.11. Paul Hartmann
  - 22.3.11.1. Overview
  - 22.3.11.2. Product Portfolio
  - 22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.11.4. Sales Footprint
  - 22.3.11.5. Key Financials
  - 22.3.11.6. SWOT Analysis
  - 22.3.11.7. Strategy Overview
- 22.3.12. Cizeta Medicali
  - 22.3.12.1. Overview
  - 22.3.12.2. Product Portfolio
  - 22.3.12.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.12.4. Sales Footprint
  - 22.3.12.5. Key Financials
  - 22.3.12.6. SWOT Analysis
  - 22.3.12.7. Strategy Overview
- 22.3.13. Belsana Medical
  - 22.3.13.1. Overview
  - 22.3.13.2. Product Portfolio
  - 22.3.13.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.13.4. Sales Footprint
  - 22.3.13.5. Key Financials
  - 22.3.13.6. SWOT Analysis
  - 22.3.13.7. Strategy Overview
- 22.3.14. Gloria Med
  - 22.3.14.1. Overview
  - 22.3.14.2. Product Portfolio
  - 22.3.14.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.14.4. Sales Footprint
  - 22.3.14.5. Key Financials
  - 22.3.14.6. SWOT Analysis
  - 22.3.14.7. Strategy Overview
- 22.3.15. Zhende Medical Group
  - 22.3.15.1. Overview
  - 22.3.15.2. Product Portfolio
  - 22.3.15.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.15.4. Sales Footprint
  - 22.3.15.5. Key Financials
  - 22.3.15.6. SWOT Analysis
  - 22.3.15.7. Strategy Overview
- 22.3.16. Maizi
  - 22.3.16.1. Overview
  - 22.3.16.2. Product Portfolio
  - 22.3.16.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.16.4. Sales Footprint
  - 22.3.16.5. Key Financials
  - 22.3.16.6. SWOT Analysis
  - 22.3.16.7. Strategy Overview
- 22.3.17. TOKO
  - 22.3.17.1. Overview
  - 22.3.17.2. Product Portfolio
  - 22.3.17.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.17.4. Sales Footprint
  - 22.3.17.5. Key Financials
  - 22.3.17.6. SWOT Analysis
  - 22.3.17.7. Strategy Overview
- 22.3.18. Okamoto Corporation
  - 22.3.18.1. Overview
  - 22.3.18.2. Product Portfolio
  - 22.3.18.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.18.4. Sales Footprint
  - 22.3.18.5. Key Financials
  - 22.3.18.6. SWOT Analysis
  - 22.3.18.7. Strategy Overview
- 22.3.19. Zhejiang Sameri
  - 22.3.19.1. Overview
  - 22.3.19.2. Product Portfolio
  - 22.3.19.3. Profitability by Market Segments (Product/Channel/Region)
  - 22.3.19.4. Sales Footprint
  - 22.3.19.5. Key Financials
  - 22.3.19.6. SWOT Analysis
  - 22.3.19.7. Strategy Overview